Literature DB >> 21826089

IBD: Trying to optimize a tool to measure disability in IBD.

Charles N Bernstein.   

Abstract

Mesh：

Year:  2011        PMID： 21826089     DOI： 10.1038/nrgastro.2011.135

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  6 in total

1.  Measures of relative importance for health-related quality of life.

Authors:  Tolulope T Sajobi; Lisa M Lix; Ian Clara; John Walker; Lesley A Graff; Patricia Rawsthorne; Norine Miller; Linda Rogala; Rachel Carr; Charles N Bernstein
Journal:  Qual Life Res       Date:  2011-04-24       Impact factor: 4.147

2.  Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers.

Authors:  Jennifer C Jaff; Janis Arnold; Athos Bousvaros
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

3.  A population-based study of health-care resource use among infliximab users.

Authors:  Zoann Nugent; James F Blanchard; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2010-04-06       Impact factor: 10.864

4.  Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study.

Authors:  M G V M Russel; B M Ryan; P C Dagnelie; M de Rooij; J Sijbrandij; A Feleus; M Hesselink; J W Muris; R Stockbrugger
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

5.  Life insurance and inflammatory bowel disease: is there discrimination against patients?

Authors:  G A Moody; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

6.  Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health.

Authors:  Laurent Peyrin-Biroulet; Alarcos Cieza; William J Sandborn; Michaela Coenen; Yehuda Chowers; Toshifumi Hibi; Nenad Kostanjsek; Gerold Stucki; Jean-Frédéric Colombel
Journal:  Gut       Date:  2011-06-05       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.